Avalyn Pharma Inc. Common Stock
Support and Resistance Levels
Past performance
News About AVLN
All events for AVLN
All deals for AVLN
Financial Ratios
Financial Statements
AVLN vs Sector & Peers
About Avalyn Pharma Inc. Common Stock
Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its clinical development phase. The company's primary focus is on creating inhaled pharmaceutical products to manage rare lung conditions, including pulmonary fibrosis and various other interstitial lung diseases (ILDs). Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar co-founded the enterprise on May 27, 2011, and its corporate headquarters are situated in Boston, Massachusetts. Website avalynpharma.com
Headquarters Boston, MA, US